Accueil>>Signaling Pathways>> Neuroscience>> COX>>Phenacetin-d5

Phenacetin-d5 (Synonyms: Acetophenetidin-d5)

Catalog No.GC66429

La phénacétine-d5 (acétophénétidine-d5) est la phénacétine marquée au deutérium. La phénacétine (acétophénétidine) est un analgésique/antipyrétique non opioÏde. La phénacétine est un inhibiteur sélectif de la COX-3. La phénacétine est utilisée comme sonde des enzymes du cytochrome P450 CYP1A2 dans les microsomes hépatiques humains et chez le rat.

Products are for research use only. Not for human use. We do not sell to patients.

Phenacetin-d5 Chemical Structure

Cas No.: 69323-74-6

Taille Prix Stock Qté
5mg
283,50 $US
En stock
10mg
450,00 $US
En stock
25mg
900,00 $US
En stock

Tel:(909) 407-4943 Email: sales@glpbio.com

Avis des clients

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents

Phenacetin-d5 (Acetophenetidin-d5) is the deuterium labeled Phenacetin. Phenacetin (Acetophenetidin) is a non-opioid analgesic/antipyretic agent. Phenacetin is a selective COX-3 inhibitor. Phenacetin is used as probe of cytochrome P450 enzymes CYP1A2 in human liver microsomes and in rats[1][2][3].

Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[1].

Avis

Review for Phenacetin-d5

Average Rating: 5 ★★★★★ (Based on Reviews and 30 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Phenacetin-d5

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.